Cyclerion Therapeutics Inc. (CYCN) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cyclerion Therapeutics In...

    NASDAQ: CYCN · Real-Time Price · USD
    2.21
    -0.01 (-0.24%)
    At close: Sep 08, 2025, 2:00 PM

    Cyclerion Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -3.06M -5.26M -44.08M -51.65M
    Depreciation & Amortization
    		 n/a n/a 65K 472K
    Stock-Based Compensation
    		 625K 1.07M 6.25M 9.61M
    Other Working Capital
    		 -619K -2.92M -4M 988K
    Other Non-Cash Items
    		 -363K -12.45M 5.24M 881K
    Deferred Income Tax
    		 n/a n/a -5.24M 2.76M
    Change in Working Capital
    		 -1.54M -4.6M -2.85M 1.41M
    Operating Cash Flow
    		 -4.33M -21.25M -40.61M -36.52M
    Capital Expenditures
    		 n/a n/a n/a -7K
    Cash Acquisitions
    		 n/a n/a n/a 1.46M
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a 10.4M n/a 1.46M
    Investing Cash Flow
    		 n/a 10.4M n/a 1.46M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a 5.02M 29K 282K
    Financial Cash Flow
    		 n/a 5.02M 29K 30.79M
    Net Cash Flow
    		 -4.34M -5.81M -40.58M -4.27M
    Free Cash Flow
    		 -4.33M -21.25M -40.61M -36.52M

    Add to Watchlist